Status:
SUSPENDED
Traumeel S for Reduction of Post Operative Pain Following Arthroscopy
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Post-operative Pain
Eligibility:
All Genders
18-40 years
Phase:
PHASE3
Brief Summary
The perception of pain is a complex process that is not yet fully understood. With outpatient knee arthroscopy becoming standard of care, postoperative pain management has become increasingly importan...
Eligibility Criteria
Inclusion
- Patients of either sex undergoing unilateral arthroscopy for menisectomy or chondroplasty, w/o ligament reconstruction .
- Age 18 - 40 years.
- Meeting none of exclusion criteria.
Exclusion
- Participation in another clinical trial within 4 weeks prior to enrollment.
- Inability to comply with the study protocol.
- Impossibility to be reached during the whole follow-up period (7 days post operative)
- Refused to give oral consent to the telephone interviews
- Previous arthroscopy on ipsilateral knee.
- Current use of analgesia for any other reason except for the knee complaint.
- Any disease considered to inhibit wound healing (e.g. Diabetes mellitus, Berger, any PVD, DVT).
- Known sensitivity to dipyrone or diclofenac
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00307892
Start Date
January 1 2011
Last Update
October 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Orthopedic Surgery, Shaare Zedek Medical Center
Jerusalem, Israel, 91031